PILOTforPulmonary: 2019 Fall Conference Coverage

Por: The France Foundation
Independent Conference Coverage from the 2019 Annual Meetings and Conferences. Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc
22 episodios disponibles

Latest episodes of the podcast PILOTforPulmonary: 2019 Fall Conference Coverage

Current Perspective on Antifibrotic Therapy for Patients with IPF
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases (The INBUILD Trial)
Goals of Care Across the Disease Continuum in IPF
Emerging Diagnostic Approaches to Patients with ILD
Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease
Considerations for Geriatric ILD Patients
Nintedanib for Patients with Systemic Sclerosis-Related Interstitial Lung Disease
Inhaled NO in Patients at Risk for Pulmonary Hypertension Associated with Pulmonary Fibrosis
Clinical Pearls from New Orleans 2019
The IPF Cell Atlas
Senescence, Senolytics, and IPF
The PRECISIONS Study
Genomics and Transcriptomics in PF
Importance of Pulmonary Fibrosis Patient Registries
Recent Developments in Methodologies to Support the Diagnosis of IPF
A New Study Evaluating Pulmonary Rehabilitation Added on to Antifibrotic Therapy
New Developments in Clinical Trials of Pulmonary Fibrosis
Exploring Antifibrotic Therapy in Patients with Autoimmune-Associated Interstitial Lung Disease
Exploring Antifibrotic Therapy in Patients with Autoimmune-Associated Interstitial Lung Disease
Expanding the Use of Antifibrotic Therapy in Patients with PF
1 2 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA